Autotransplantation and culture of cryopreserved ovarian tissue for fertility preservation in patients with cancer or immunologic diseases
- Conditions
- Breast cancer, leukemia, malignant lymphoma (Hodgkin's and Non-Hodgkin's), other hematopoietic diseases (hypoplastic anemia, myelodysplastic syndrome, myeloma), sarcoma, systemic lupus erythematosus, rheumatic arthritis and other diseases requiring alkylating agents or radiotherapy
- Registration Number
- JPRN-UMIN000016428
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Not provided
A patient is excluded from cryopreservation if: 1 she has a serious complication 2 she is unable to judge appropriately or unable to declare her wishes 3 this study will seriously delay the treatment for her primary disease 4 the physician treating her primary disease has decided that this study is not suitable for her A patient is excluded from autotransplantation if: 1 she has a serious complication 2 she is unable to judge appropriately or unable to declare her wishes 3 autotransplantation is a serious risk for her
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pregnancy rate by autotransplantation of cryopreserved ovarian tissue
- Secondary Outcome Measures
Name Time Method